Supernus Pharmaceuticals | Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
ANI Pharmaceuticals USD 21.73M 21.73M 2025-06
Aurora Cannabis CAD 6.98B 907K 2024-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 332.38M 127.23M 2025-09
Cara Therapeutics USD 2K 3K 2025-03
Corcept Therapeutics USD 105.12M 164K 2025-09
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Novo Nordisk DKK 4.44B 0 2025-12
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 0 2025-09
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
United Therapeutics USD 42.9M 42.1M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09


Supernus Pharmaceuticals Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.